• Investment Boost for Ascribe Bio – Agritech company Ascribe Bio secured significant funding from ICIG Ventures to accelerate the commercialization of its innovative biofungicide, Phytalix®.
• Phytalix as a Game-Changer – This small molecule-based solution, derived from the soil microbiome, offers a scalable, cost-effective, and high-performance alternative to traditional chemical fungicides.
• Addressing Global Crop Protection Challenges – With crop diseases causing up to 25% of annual yield losses, Phytalix provides a sustainable, science-backed solution to overcome resistance issues and performance barriers in existing products.
• Shaping the Future of Agriculture – Ascribe Bio’s breakthrough aligns with sustainability goals, gaining strong backing from ICIG Ventures, which sees Phytalix as a crucial step toward resilient and eco-friendly food systems.
Ascribe Bio, an innovative agritech company, has announced a significant investment from ICIG Ventures, marking a major milestone in the commercialization of its groundbreaking biofungicide, Phytalix®. This funding will accelerate the launch of Phytalix, a small molecule-based solution derived from the soil microbiome, designed to address critical challenges in modern agriculture.
Phytalix represents a transformative approach to crop protection, offering a cost-effective, scalable, and high-performance alternative to traditional chemical fungicides and existing biologicals. Unlike many biological solutions that face limitations in scalability and integration, Phytalix seamlessly fits into conventional agricultural systems, reducing risk for farmers while delivering proven efficacy.
Download the Ebook now
With crop diseases and damage accounting for up to 25% of annual yield losses globally, the need for sustainable and effective crop protection solutions has never been greater. Chemical solutions are increasingly losing their effectiveness due to resistance, while biological alternatives often struggle with cost and performance barriers. Phytalix bridges this gap, providing a science-backed, scalable solution that aligns with both financial and sustainability goals for farmers, consumers, and the ag-input industry.
Gabriel Wilmoth, Jay Farmer, and the Ascribe Bio team are at the forefront of unlocking the potential of natural crop protection. Their work is poised to reshape the future of agriculture by offering a product that not only works but also supports the transition to more sustainable farming practices.
Pelin Yilmaz of ICIG Ventures expressed excitement about supporting Ascribe Bio’s mission, emphasizing the importance of innovations like Phytalix in building resilient and sustainable food systems. This partnership underscores ICIG Ventures’ commitment to visionary solutions that address pressing global agricultural challenges.
For agritech startups seeking investment and scaling support, this collaboration serves as a testament to the growing interest in sustainable agricultural innovations. As Ascribe Bio moves closer to bringing Phytalix to market, the agritech community eagerly anticipates the impact this breakthrough product will have on the future of farming.
